Shijie Sheng

7.4k total citations · 2 hit papers
85 papers, 6.0k citations indexed

About

Shijie Sheng is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Shijie Sheng has authored 85 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 41 papers in Cancer Research and 19 papers in Oncology. Recurrent topics in Shijie Sheng's work include Protease and Inhibitor Mechanisms (35 papers), Bone and Dental Protein Studies (13 papers) and Peptidase Inhibition and Analysis (11 papers). Shijie Sheng is often cited by papers focused on Protease and Inhibitor Mechanisms (35 papers), Bone and Dental Protein Studies (13 papers) and Peptidase Inhibition and Analysis (11 papers). Shijie Sheng collaborates with scholars based in United States, China and France. Shijie Sheng's co-authors include Ruth Sager, Mary J.C. Hendrix, Elisabeth A. Seftor, Hailong Wu, Yin-Yuan Mo, Daotai Nie, Fangting Wu, Arthur B. Pardee, Meng Qiao and Philip A. Pemberton and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Shijie Sheng

82 papers receiving 5.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MicroRNA-21 targets tumor suppressor genes in invasion and metastasis

2008 894 citations Hailong Wu, Fangting Wu et al. Cell Research profile →
Maspin, a Serpin with Tumor-Suppressing Activity in Human Mammary Epithelial Cells

1994 782 citations Shijie Sheng et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shijie Sheng United States	40	3.7k	2.9k	1.6k	561	529	85	6.0k
Viktor Magdolen Germany	46	3.0k 0.8×	2.6k 0.9×	2.0k 1.3×	168 0.3×	326 0.6×	202	6.4k
Peter A. Andreasen Denmark	44	2.9k 0.8×	4.5k 1.6×	1.5k 1.0×	186 0.3×	467 0.9×	158	7.2k
Jack Henkin United States	42	2.5k 0.7×	2.1k 0.7×	1.3k 0.8×	125 0.2×	532 1.0×	111	4.8k
Giulia Taraboletti Italy	47	4.0k 1.1×	2.2k 0.8×	2.1k 1.3×	192 0.3×	506 1.0×	112	7.1k
Lalita A. Shevde United States	41	4.5k 1.2×	1.6k 0.5×	2.5k 1.6×	332 0.6×	1.0k 2.0×	105	6.9k
Karen Blyth United Kingdom	43	4.7k 1.3×	2.2k 0.8×	1.9k 1.1×	158 0.3×	563 1.1×	134	7.0k
Sandra R. Wolman United States	32	2.5k 0.7×	1.6k 0.6×	1.5k 0.9×	254 0.5×	478 0.9×	103	4.8k
L. A. Liotta United States	21	3.0k 0.8×	1.8k 0.6×	1.7k 1.0×	121 0.2×	483 0.9×	39	4.9k
Yinkun Liu China	43	3.4k 0.9×	1.3k 0.5×	1.3k 0.8×	177 0.3×	411 0.8×	200	5.5k
Karin Milde‐Langosch Germany	42	3.2k 0.9×	1.8k 0.6×	1.9k 1.2×	111 0.2×	551 1.0×	130	5.6k

Countries citing papers authored by Shijie Sheng

Since Specialization

Citations

This map shows the geographic impact of Shijie Sheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shijie Sheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shijie Sheng more than expected).

Fields of papers citing papers by Shijie Sheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shijie Sheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shijie Sheng. The network helps show where Shijie Sheng may publish in the future.

Co-authorship network of co-authors of Shijie Sheng

This figure shows the co-authorship network connecting the top 25 collaborators of Shijie Sheng. A scholar is included among the top collaborators of Shijie Sheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shijie Sheng. Shijie Sheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Jian, et al.. (2025). Corosolic acid increases the therapeutic effect of cisplatin on gastric cancer by regulating Gpx4-dependent ferroptosis. Cancer Drug Resistance. 8. 40–40.

Ji, Lin, Jia Chen, Ying‐Ping Wang, et al.. (2019). Therapeutic potential of pravastatin for random skin flaps necrosis: involvement of promoting angiogenesis and inhibiting apoptosis and oxidative stress. SHILAP Revista de lepidopterología.

Sheng, Shijie, M. Margarida Bernardo, Sijana H. Dzinic, et al.. (2018). Tackling tumor heterogeneity and phenotypic plasticity in cancer precision medicine: our experience and a literature review. Cancer and Metastasis Reviews. 37(4). 655–663. 18 indexed citations

Kidder, Benjamin L., Runsheng He, Darawalee Wangsa, et al.. (2017). SMYD5 Controls Heterochromatin and Chromosome Integrity during Embryonic Stem Cell Differentiation. Cancer Research. 77(23). 6729–6745. 27 indexed citations

Bernardo, M. Margarida, Alexander Kaplun, Sijana H. Dzinic, et al.. (2015). Maspin Expression in Prostate Tumor Cells Averts Stemness and Stratifies Drug Sensitivity. Cancer Research. 75(18). 3970–3979. 19 indexed citations

Wang, Yang, Shijie Sheng, Jianzhi Zhang, et al.. (2013). Elevated Maspin Expression Is Associated with Better Overall Survival in Esophageal Squamous Cell Carcinoma (ESCC). PLoS ONE. 8(5). e63581–e63581. 19 indexed citations

Lonardo, Fulvio, Xiaohua Li, Alexander Kaplun, et al.. (2010). The Natural Tumor Suppressor Protein Maspin and Potential Application in Non Small Cell Lung Cancer. Current Pharmaceutical Design. 16(16). 1877–1881. 29 indexed citations

Yue, Zhixia, et al.. (2010). The n-terminal 5-MER peptide analogue P165 of amyloid precursor protein exerts protective effects on SH-SY5Y cells and rat hippocampus neuronal synapses. Neuroscience. 173. 169–178. 15 indexed citations

Cai, Juan, Pridvi Kandagatla, Rajareddy Singareddy, et al.. (2010). Androgens Induce Functional CXCR4 through ERG Factor Expression in TMPRSS2-ERG Fusion-Positive Prostate Cancer Cells. Translational Oncology. 3(3). 195–IN1. 45 indexed citations

10.

Dong, Zhong, Allen Saliganan, Meng Hong, et al.. (2008). Prostate Cancer Cell-Derived Urokinase-Type Plasminogen Activator Contributes to Intraosseous Tumor Growth and Bone Turnover. Neoplasia. 10(5). 439–449. 37 indexed citations

11.

Wu, Hailong, et al.. (2008). MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Research. 18(3). 350–359. 894 indexed citations breakdown →

12.

Lockett, Jaron, Shuping Yin, Xiaohua Li, Yonghong Meng, & Shijie Sheng. (2005). Tumor suppressive maspin and epithelial homeostasis. Journal of Cellular Biochemistry. 97(4). 651–660. 79 indexed citations

13.

Sheng, Shijie, et al.. (2005). Maspin sensitizes prostate cancer cells to doxazosin-induced apoptosis. Oncogene. 24(34). 5375–5383. 32 indexed citations

14.

Sheng, Shijie. (2004). The promise and challenge toward the clinical application of maspin in cancer. Frontiers in bioscience. 9(1-3). 2733–2733. 39 indexed citations

15.

Reddy, Kaladhar B., et al.. (2001). Maspin expression inversely correlates with breast tumor progression in MMTV/TGF-alpha transgenic mouse model. Oncogene. 20(45). 6538–6543. 23 indexed citations

16.

Sheng, Shijie. (2001). The Urokinase-type Plasminogen Activator System in Prostate Cancer Metastasis. Cancer and Metastasis Reviews. 20(3-4). 287–296. 61 indexed citations

17.

Meng, Xiaofeng, Shijie Sheng, Ning Zhu, et al.. (2001). Formation and identification of 4'-O-methyl-(-)-epigallocatechin in humans.. PubMed. 29(6). 789–93. 58 indexed citations

18.

Sheng, Shijie, et al.. (1999). Remangilones A−C, New Cytotoxic Triterpenes from Physena madagascariensis. Journal of Natural Products. 62(3). 471–476. 14 indexed citations

19.

Liu, Yiliang E., Ming‐Sheng Wang, J. M. Greene, et al.. (1997). Preparation and Characterization of Recombinant Tissue Inhibitor of Metalloproteinase 4 (TIMP-4). Journal of Biological Chemistry. 272(33). 20479–20483. 110 indexed citations

20.

Wang, Ming‐Sheng, J. M. Greene, Shijie Sheng, et al.. (1997). Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4. Oncogene. 14(23). 2767–2774. 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact